Loading chat...
IN SR0018
Resolution
AI Summary
-
Urges the legislative council to assign prescription drug pricing and access to specialty prescription drugs as topics for study by the appropriate committee
-
Notes that FDA specialty drug approvals exceeded traditional drug approvals for the first time in 2010, with this trend continuing annually
-
Cites Centers for Medicare and Medicaid Services projections of sustained drug spending increases of 6% or more annually from 2015 to 2022
-
References 2014 U.S. prescription drug spending of nearly $379 billion, with approximately one-third spent on specialty drugs
Legislative Description
A SENATE RESOLUTION urging the legislative council to assign to the appropriate study committee the topics of prescription drug pricing and access to specialty prescription drugs.